Please login to the form below
medicines shortages
This page shows the latest medicines shortages news and features for those working in and with pharma, biotech and healthcare.
India’s export curbs raise fears of global drug shortages
Pharmexcil has been reported in the Indian press as saying the measures are designed to prevent domestic shortages of these medicines and that “irrespective of the ban, some of these molecules ... It also said that if the coronavirus outbreak isn’t
Latest news
-
The NHS is facing shortages of lifesaving treatments, says internal document
Shortages of medicines risk price distortion at the expense of health budgets, disrupt patient drug regimes and can undermine public health objectives. ... This worrying document comes on the heels of the UK Government publishing a list of medicines
-
Significant gaps remain in UK’s no-deal Brexit prep, says NAO report
Medicine supply still under threat despite preparedness programme. A no-deal Brexit could still threaten supplies of medicines to the NHS and care homes, despite the UK government’s preparedness programme, ... shortages of vital medicines, despite the
-
Brexit causing ‘significant’ generic drug shortages
Generics firms contest reason for shortages. Pharmacies in England are reporting a ‘significant’ shortage in some medicines, warns the sector's Pharmaceutical Services Negotiating Committee (PSNC), and claims that Brexit is ... The news builds on a
-
As government rushes through no-deal legislation, UK biotech repeats Brexit plea
UK market would be relegated in importance. The UK government has begun rushing swathes of emergency legislation through Parliament, which would allow medicines regulation to function in the event of a ... SIs have been laid before Parliament covering
-
Industry frustrated by late warning on 'no deal' Brexit disruption
It is most afraid of being blamed for any medicines shortages in the event of a no deal Brexit. ... roll-off freight capacity and that medicines and medical products will be prioritised on alternative routes.”.
More from news
Approximately 1 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
EU Pharmaceutical Strategy Roadmap
The debates around access, availability (including shortages) and affordability of medicines are not new. ... Orphan Medicinal Products were a major focus. The European Parliament also adopted a resolution in 2017, on possible EU options for improving
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- The pharma dichotomy
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
